Brief: Acumen Pharmaceuticals Announces $35.75 Million Private Placement To Advance Potential Best-In-Class Molecules From Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
16/03/2026 10:38
March 16 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O: ACUMEN PHARMACEUTICALS ANNOUNCES $35.75 MILLION PRIVATE PLACEMENT TO ADVANCE POTENTIAL BEST-IN-CLASS MOLECULES FROM AMYLOID BETA OLIGOMER-SELECTIVE ENHANCED BRAIN DELIVERY PORTFOLIO Source text: ID:nGNX9ZtJhN Further company coverage: ABOS.O ((((Reuters.Briefs@thomsonreuters.com;));))